Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03015129 | A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer | completed | Phase 2 | 80 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT00471601 | Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions | completed | N/A | 357 | Memorial Sloan Kettering Cancer CenterOTHER | 3 | Jan 2, 2024 |
| NCT02836093 | Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment | completed | — | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT05071014 | A Study of Pembrolizumab and Cryoablation in People With Mesothelioma | completed | Phase 1 | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 20, 2023 | clinicaltrials |
| NCT03070340 | Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery | completed | N/A | 125 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 21, 2023 | clinicaltrials |
| NCT02713022 | Body Composition and White Adipose Tissue Inflammation | completed | — | 202 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT00587431 | Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer | completed | Phase 2 | 102 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT01522768 | Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer | completed | Phase 2 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT04210128 | Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment | completed | — | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT00588523 | Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma | completed | Phase 2 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT00590993 | Magnetic Resonance Imaging and Spectroscopy of the Prostate | completed | — | 1,005 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT02070575 | Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence | completed | — | 200 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT03399552 | Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma | completed | Phase 1 / Phase 2 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 23, 2023 | clinicaltrials |
| NCT04170231 | Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses | completed | — | 93 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | completed | Phase 2 | 81 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT02477202 | Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation | completed | N/A | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT00579423 | Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer | completed | Phase 2 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT01268579 | Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma | completed | N/A | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2023 | clinicaltrials |
| NCT00574496 | Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma | completed | Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT00588198 | Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma | completed | — | 754 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT00610883 | LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma | completed | Phase 2 | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT00591851 | Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility | completed | Phase 2 | 70 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT02803203 | Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers | completed | Phase 1 / Phase 2 | 49 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT00582270 | Prospective Study of Possible Infectious Disease - Associated Antigen Drive in Previously Untreated Indolent Lymphoma | completed | — | 56 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT00562640 | Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT00591279 | Cancer Control Following Polypectomy | completed | — | 110 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 13, 2023 | clinicaltrials |
| NCT02836522 | Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) | completed | — | 406 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT02726360 | Physician Use of Non-English Language Skills in Cancer Care | completed | — | 71 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 23, 2023 | clinicaltrials |
| NCT04104217 | A Study of the Experience of Music Therapy in Cancer Patients With Delirium | completed | — | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT00539643 | Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma | completed | Phase 2 | 101 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT01484093 | Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma | completed | Phase 1 / Phase 2 | 96 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 16, 2023 | clinicaltrials |
| NCT01419834 | Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors | completed | Phase 1 | 68 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 4, 2023 | clinicaltrials |
| NCT00591370 | Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT03300284 | Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer | completed | — | 186 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT03276481 | Prospective Evaluation of Taste Function In Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation | completed | — | 47 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT00200174 | Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease | completed | N/A | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 5, 2023 | clinicaltrials |
| NCT00606294 | Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients | completed | N/A | 216 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT03178045 | Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients | completed | — | 2,793 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 23, 2023 | clinicaltrials |
| NCT02364726 | Acupuncture to Reduce Chemotherapy-induced Peripheral Neuropathy Severity During Neoadjuvant or Adjuvant Weekly Paclitaxel Chemotherapy in Breast Cancer Patients | completed | N/A | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT02806037 | Utility of Intra-operative Image Guidance System for Missing Metastases | completed | — | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Jun 18, 2023 | clinicaltrials |
| NCT01534104 | MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning | completed | N/A | 145 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT00717795 | Physical Activity Intervention for Lung Cancer Survivors | completed | — | 52 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 7, 2023 | clinicaltrials |
| NCT02106507 | ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate | completed | Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 26, 2023 | clinicaltrials |
| NCT02309580 | Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma | completed | Phase 1 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT00582062 | Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples | completed | — | 144 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT03310541 | AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT01974765 | Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies | completed | Phase 2 | 59 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT04872608 | A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer | withdrawn | Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 28, 2023 | clinicaltrials |
| NCT02278055 | Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 29 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT02737787 | A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer | completed | Phase 1 | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 7, 2023 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials